awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42739081-03307513-8747-44FA-B01F-3A12F55B18A6
Q42739081-03307513-8747-44FA-B01F-3A12F55B18A6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42739081-03307513-8747-44FA-B01F-3A12F55B18A6
Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors.
P2860
Q42739081-03307513-8747-44FA-B01F-3A12F55B18A6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42739081-03307513-8747-44FA-B01F-3A12F55B18A6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1e8c76043559206a83b991d2b526566572ff5eb7
P2860
Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors.